RecruitingPhase 4NCT06498505

HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men

Studying High altitude pulmonary edema

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Zurich
Principal Investigator
Silvia Ulrich, Prof. Dr.
University of Zurich
Intervention
Acetazolamide(drug)
Enrollment
270 target
Eligibility
18-44 years · All sexes
Timeline
20242025

Study locations (1)

Collaborators

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov · University Hospital Heidelberg · Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06498505 on ClinicalTrials.gov

Other trials for High altitude pulmonary edema

Additional recruiting or active studies for the same condition.

See all trials for High altitude pulmonary edema

← Back to all trials